Chong Yu to Retreatment
This is a "connection" page, showing publications Chong Yu has written about Retreatment.
Connection Strength
0.324
-
Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan. Cancer Med. 2017 Jul; 6(7):1563-1572.
Score: 0.165
-
Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter retrospective SEQUENCE study. Lung Cancer. 2017 02; 104:58-64.
Score: 0.159